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Abstract
Background: The relationship between geographical location, private costs, health provider costs
and uptake of health screening is unclear. This paper examines these relationships in a screening
programme for abdominal aortic aneurysm in the Highlands and Western Isles of Scotland, a rural
and remote area of over 10,000 square miles.
Methods: Men aged 65–74 (n = 9323) were invited to attend screening at 51 locations in 50
settlements. Effects of geography, deprivation and age on uptake were examined. Among 8,355
attendees, 8,292 completed a questionnaire detailing mode of travel and costs incurred, time
travelled, whether accompanied, whether dependants were cared for, and what they would have
been doing if not attending screening, thus allowing private costs to be calculated. Health provider
(NHS) costs were also determined. Data were analysed by deprivation categories, using the
Scottish Indices of Deprivation (2003), and by settlement type ranging from urban to very remote
rural.
Results: Uptake of screening was high in all settlement types (mean 89.6%, range 87.4 – 92.6%).
Non-attendees were more deprived in terms of income, employment, education and health but
there was no significant difference between non-attendees and attendees in terms of geographical
access to services. Age was similar in both groups. The highest private costs (median £7.29 per
man) and NHS screening costs (£18.27 per man invited) were observed in very remote rural areas.
Corresponding values for all subjects were: private cost £4.34 and NHS cost £15.72 per man
invited.
Conclusion: Uptake of screening for abdominal aortic aneurysm in this remote and rural setting
was high in comparison with previous studies, and this applied across all settlement types.
Geographical location did not affect uptake, most likely due to the outreach approach adopted.
Private and NHS costs were highest in very remote settings but still compared favourably with
other published studies.
Background
Screening for abdominal aortic aneurysm (AAA) has been
carried out in the UK for over twenty years. The effective-
ness of this intervention in detection and management of
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abdominal aortic aneurysms has been the subject of
debate in the literature [1-5]. However, recent evidence
suggests that screening for AAA can be clinically and cost
effective in reducing aneurysm mortality among men aged
65–74 years [6-8].
The effectiveness of screening programmes has tended to
be measured by the level of compliance or uptake, higher
compliance equating with higher detection [9-11].
Although this approach has been questioned [12], it
remains a key aspect in evaluations, particularly in the
period prior to establishing national screening pro-
grammes. A systematic review of factors associated with
uptake in various screening programmes identified a
number of socio-demographic, attitudinal, social and
health factors which influence compliance [13]. In that
review, effects of geographical location on uptake were
inconclusive. Geographical location of subjects and
screening centres affects access to transport, distance to
travel and costs of attending, including out-of-pocket
expenses and the opportunity cost of time attending
screening, i.e. time that could have been spent undertak-
ing another activity.
Recent studies have suggested that private costs ought to
be considered in screening evaluations [10,14-16]. Evi-
dence on the impact of cost on uptake has tended to orig-
inate from the United States where screening incurs a
charge [13]. While screening in the United Kingdom is
typically offered free of charge, this overlooks the poten-
tially considerable cost to the individual and the wider
societal cost, for example through loss of productivity and
care of dependants [10].
The cost-effectiveness of screening has generally been con-
sidered from a health care provider perspective, as in the
recent UK multi-centre aneurysm screening study
(MASS)[8]. Recognising the direct and indirect financial
costs incurred by those invited to participate in a screen-
ing programme is beginning to form part of the evalua-
tion process [10,17,18]. This is particularly relevant in
remote and rural areas where access to screening may be
limited by the availability of public transport and prohib-
itive costs associated with travel to screening centres
[5,14,19].
Evidence suggests that rural residents face barriers in
access to preventive health measures in comparison with
urban residents, and, as a result, uptake has been typically
low in rural areas [20]. This study considers the costs
incurred by men participating in an AAA screening pro-
gramme in the Highlands and Western Isles – a remote
and rural area of the UK. In an attempt to overcome
potential effects of rurality on uptake, screening was
offered at many sites throughout the region. Potential dif-
ferences arising from geographical location, and the asso-
ciated private costs incurred, were explored in relation to
the uptake of screening.
Methods
The Highland Aneurysm Screening Programme (HASP)
was established in 2001 to offer men in Highland and
Western Isles aged 65–74 years screening for abdominal
aortic aneurysm. Men born between 1927 and 1936, and
currently registered with general practitioners (GPs) in
Highland and Western Isles, were identified from Practi-
tioner Services Division. GPs were asked to review lists
and remove men who were no longer patients either due
to death or moving away, or for whom an invitation to
screening would be inappropriate due to known co-mor-
bidity or previous aneurysm surgery. Invitations to attend
a local screening session were sent out with an informa-
tion leaflet and the opportunity to rearrange appointment
time and date. One further invitation was sent to non-
attendees. GPs were notified of patients who did not
attend, and the file on each non-attendee was closed at
that time.
A sonographer and screening nurse using a portable scan-
ner carried out the screening sessions, at urban and com-
munity hospitals and general practice premises. Screening
was offered at fifty-one locations across Highland and the
Western Isles between February 2001 and January 2004.
The land area of Highland (26,484 square kilometres)
represents one third of Scotland and has a population of
just over 208,000: 8 persons per square kilometre. The
Western Isles, comprising sixty-six islands, many unin-
habited, has a population of approximately 26,500 cover-
ing an area of 3,000 square kilometres.
Each man attending screening was asked to complete a
questionnaire, providing information on the method of
transport used to travel to the session; the duration of the
journey; miles travelled by car users and costs incurred
from public transport or taxi use. In addition they were
asked whether they had taken time off work; whether
wages had been lost as a result of attending; if they had
been accompanied to the screening session and whether
dependants had to be cared for to enable them to attend.
Direct costs to the individual were identified as out-of-
pocket expenses arising from attending the screening ses-
sion. The direct cost of travel was based on the actual cost
of the return journey for those travelling by public trans-
port or taxi. The cost of car travel was calculated at 45
pence per mile [21]. Wages lost calculations were based
on information provided by participants or estimated
using New Earnings Survey rates [22].
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Indirect costs refer to the activity or opportunity foregone
as a consequence of attending screening. In this study, the
opportunity cost was calculated for men attending screen-
ing, their companion, if accompanied, and carer of
dependants, where relevant. The rate was estimated at
£3.79 per hour and was based on travel time [10,23].
Time spent at the screening session was not included. This
rate was also applied to those who accompanied men to
the screening session and the carer's time, where relevant.
All financial estimates were based on financial year 2002/
2003.
Remoteness was classified using the Scottish Household
Survey (SHoS) eight-fold classification of settlements
[24]. This classification, based on settlement size and
drive times, was applied to the general practice at which
each man was listed and to the screening sites. Using pop-
ulation data from the 2001 Census and Scottish Ambu-
lance Service estimated drive time, each location was
assigned a SHoS category. Postcodes of men invited to
attend for screening were linked to the Scottish Indices of
Deprivation 2003 [25], which are based on electoral
wards. As well as providing an overall Index of Multiple
Deprivation (SIMD), this has five domains, including
income, employment, education, health, and geographi-
cal access to services.
NHS costs were calculated on the basis of prices for the
2002–3 financial year, and included administrative and
staff cost as well as cost of equipment, as previously
described [26]. We assumed an opportunity cost of zero
for using NHS premises for screening, although our finan-
cial estimates could be altered to include a fee per session.
Differences between screening locations reflected the var-
iation in travel expenses and costs of travel time for the
screening staff to attend each site. Central costs associated
with administration of the programme and the costs of
staff time for the screening session itself were assigned the
same rates for all screening locations.
Data analysis was performed in SPSS version 14®. Mann-
Whitney tests and unpaired t-tests were used to compare
characteristics of non-attendees and attendees. Differ-
ences between settlement categories in respect of travel
time, distance travelled and patient costs were explored
using Kruskal-Wallis tests.
The Highland Research Ethics Committee approved the
programme.
Results
Study sample
The Practitioner Services Division identified 9657 men in
the appropriate age group. After excluding those who died
before an appointment could be sent, or were no longer
in the practice area or not at the address given, or were
deemed inappropriate on grounds of co-morbidity or pre-
vious aneurysm surgery, 9323 were invited. For analysis
purposes, useable postcodes for linkage to SIMD scores
were available from 8542 (92%). Other postcodes were
either missing or incomplete, or could not be matched to
an electoral ward. Of those men invited, 8355 (89.6%)
attended between April 2001 and January 2004 and 8,292
provided questionnaires.
The clinical outcomes of the programme have been pub-
lished in detail elsewhere [26]. Uptake was high in all set-
tlement types: urban 89.6%; accessible small town 87.9%;
remote small town 87.4%; very remote small town 88.7%;
accessible rural area 92.6%; remote rural area 92%; very
remote rural area 88.9%. Of men screened, 430 (5.1%)
had aortic diameter greater than 30 mm, indicative of
aneurysm, and 40 (0.5%) had aortic diameter greater than
54 mm, the level at which surgery would be offered.
Characteristics of attendees and non-attendees are shown
in table 1. Non-attendees were slightly more deprived on
the overall Index of Multiple Deprivation (SIMD) and on
most of the domains (Income, Employment, Education
Table 1: Characteristics of Non-attendees and Attendees
Variable Non-attendees Attendees Significance
N 844 7968
SIMD Score* 19.83 (11.35) 17.27 (11.8) < 0.0001
Income Domain Score* 13.33 (7.34) 12.38 (6.76) < 0.0001
Employment Domain Score* 13.64 (6.97) 12.38 (6.80) < 0.0001
Education Domain Score* -0.15 (0.86) -0.30 (0.82) < 0.0001
Health Domain Score* -0.13 (0.69) -0.26 (0.71) < 0.0001
Access Score* 1.01 (1.83) 0.96 (1.73) 0.832
Mean (SD) Age*** (Years) 70.09 (2.93) 69.88 (2.88) 0.047
SIMD is the Scottish Index of Multiple Derivation composite score. All scores are shown as median (IQR) *Higher values indicate more deprived. 
**Age in years at date of file closure for non-attendees and date of attendance for attendees.
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and Health). However, there was no significant difference
between non-attendees and attendees on the Geographi-
cal Access to Services domain. Non-attendees were older
than attendees, the mean difference being 2.4 months.
However, since age was calculated for non-attendees at
the date the file was closed, i.e. after a repeat appointment
had been sent, but for attendees at the date of attendance,
this difference probably reflects the time necessary to send
a second appointment and close the file.
Travel – Mode of transport
The method of travel used by men to attend screening, cat-
egorised by the location where screening took place, is
shown in Table 2. Most men in all location categories trav-
elled by car (83%). One in ten men walked to the session.
The relative lack of availability of public transport is
reflected in the small number of men using bus (5%) and
train travel (0.1%). Significant differences were noted
across the locations (X2 = 315.9, p < 0.005). The greatest
proportion of men travelling by bus was in urban areas,
while the greatest proportion travelling by car was in very
remote rural areas.
Travel – Time travelled
Table 3 shows median journey times across the location
categories. Significant differences in median journey time
(X2 = 257.6, p < 0.005) were noted. Men screened in urban
and very remote rural areas spent more time travelling
than men in other locations.
Work/Activity foregone
A small proportion of men took time off work to attend
screening (n = 325; 4%). Men no longer in employment
had typically given up leisure pursuits to attend (67%).
Companions and dependants
The majority of men attended screening alone (79%).
16% attended with a partner, 4% with a friend. The major-
ity of companions had given up housework to accompany
men (62%). Few men reported having to arrange for
dependants to be looked after to enable them to attend
screening (5%). Carers most frequently had foregone
housework to look after dependants (48%).
Costs
The private and NHS costs of the screening programme
are shown in Table 3. The components of the private cost
Table 2: Mode of travel to screening by screening location
Settlement Category Car Taxi Bus Train Foot Other
Urban* 1548 (77) 38 (2) 204(10) 2(0.1) 138 (7) 72 (4)
Accessible small town 606 (85) 8 (1) 23 (3) 1 (0.1) 74 (10) 4 (0.6)
Remote small town 221 (79) 2 (0.7) 6 (2) 0 49 (18) 1 (0.4)
Very remote small town 1685 (83) 49 (2) 97 (5) 4 (0.2) 181 (9) 14 (0.7)
Accessible rural 630 (83) 0 14 (2) 0 101 (13) 9 (1)
Remote rural 1012 (85) 4 (0.3) 15 (1) 0 136 (11) 21 (2)
Very remote rural 1156 (87) 11 (0.8) 36 (3) 1 (0.1) 102 (8) 17 (1)
All Settlements 6858 (83) 112 (1) 395 (5) 8 (0.1) 781 (9) 138 (2)
Data are n (%) *Urban, 10,000 –125,000 inhabitants. Classification of other areas based on settlement size and drive time to settlement of more 
than 10,000 inhabitants: Small town, 3,000–10,000; Rural, less than 3,000; Accessible, within 30 minutes drive; Remote, 30–60 minutes drive; Very 
remote, more than 60 minutes drive.
Table 3: Travel time, private cost and NHS cost of attending screening by screening location
Settlement Category Travel Time (round trip) 
minutes Median (IQR)
Private Cost (£) Median 
(IQR)
NHS cost per session (£) NHS cost per man invited 
(£)
Urban 30 (20) 4.2 (4.05) 248.79 14.34
Accessible small town 20 (20) 4.00 (4.86) 286.43 14.58
Remote small town 20 (20) 4.86 (7.83) 294.96 15.99
Very remote small town 20 (20) 3.96 (7.94) 274.65 14.56
Accessible rural 20 (20) 3.96 (5.76) 307.38 15.66
Remote rural 20 (30) 4.59 (8.87) 305.04 16.77
Very remote rural 30 (20) 7.29 (10.53) 332.66 18.27
All settlements 20 (30) 4.34 (6.85) 288.44 15.72
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incurred by an individual attending screening were: travel,
companion travel, work or activity foregone and care of
dependants. Overall, the median private cost was £4.34.
Private costs differed by location (X2 = 136.5, p < 0.005).
Men attending screening in very remote rural locations
incurred the greatest private cost. NHS costs per session
and per man screened were highest in the remote and very
remote rural locations, reflecting the travel time and travel
costs incurred by staff.
Discussion
In this study, carried out in a rural and remote region of
the United Kingdom, overall uptake of screening for AAA
was 89.6%. This is higher than previous UK and European
AAA screening studies (MASS 80%[7];Gloucester
84%[27]; Viborg, Denmark 76%[28]; Nijmegen, Nether-
lands 83%[29]). Non-attendees were more deprived than
attendees, but geographical location of residence of those
invited did not affect attendance. Private costs of attend-
ance were highest for those screened in the most remote
locations, as were NHS costs.
The high level of uptake in remote and rural locations
contrasts with literature on the impact of rurality on access
to preventive health services [30-33]. In an urban/rural
comparison in the USA it was noted that after controlling
for age, income, gender, education, race and ethnicity,
rural residents remained less likely to access preventive
health services [19]. The authors acknowledged that rural
areas present particular challenges in improving access to
preventive services and identify distance to travel and
associated costs as an important factor. In addition poor
quality roads and higher fuel costs were cited as an expla-
nation for rural/urban differences in access to health care
in Australia [33]. However, research in a rural area of
Michigan concluded that travel time and distance were
not associated with breast screening compliance,
although the authors acknowledged that further research
was required in a more remote area to explore the issue
further [34]. In the current study, we believe that the
potential negative effect of rural residence on uptake was
overcome by taking screening sessions to as local a level as
possible, primarily general practice premises.
The remote and rural nature of Highland and Western
Isles meant that in many of the locations public transport
was either not available or so limited that it was not a fea-
sible option for attending screening. This was reflected in
greater car use in the very remote rural areas. Time spent
travelling was greatest for men living in the very remote
rural and urban categories. This reflects the more distrib-
uted nature of very remote rural populations. In contrast,
high travel times for those screened in urban areas are
likely to reflect greater use of public transport and greater
traffic congestion.
In a previous comparison of attendees and non-attendees
in a remote rural mobile breast screening programme, it
was found that non-attendees lived a greater distance
from the mobile screening unit than participants. Keeping
of appointment times was closely associated with the
availability of public transport and those with appoint-
ments in the afternoon had the most difficulty in attend-
ing due to the absence of public transport at that time of
day [14]. In our study, less than 5% of subjects travelled
to screening appointments by public transport, and
uptake of screening did not relate to the geographical
access score of subjects' residences.
A review of factors that influence uptake of screening con-
cluded that cost could not reliably be considered within
the United Kingdom setting, in contrast with the United
States where screening incurs a charge [13]. However,
research in the UK has suggested that high private costs
may act as a disincentive to attend preventive screening
[10,15]. The evidence on the impact of private costs
remains inconclusive. A study of patient costs in a hospital
based AAA screening programme in Denmark found there
was no correlation between costs to the individual and
attendance rates [17]. However, in that study, opportunity
foregone costs were calculated only for men in employ-
ment and therefore did not include the time costs of com-
panions or those who had retired. That approach assigned
no value to the time or activities given up by those who
were not in employment. In our study, only a small
number of men took time off work to attend screening (n
= 325). The predominance of retired men had a consider-
able impact on the opportunity cost of time, reducing
both the potential cost to the individual in terms of wages
lost and the wider societal cost through lost productivity.
In addition, less than a quarter of men (n = 1754) were
accompanied to screening, lowering the wider societal
cost. However, our finding that non-attendees had greater
levels of material deprivation raises the possibility that
cost may have influenced the decision to attend screening.
Higher age and social deprivation were associated with
poorer attendance at screening and follow up in the MASS
trial [35].
In an economic evaluation of outreach assessment clinics
for breast screening on three Scottish islands, higher
health service costs were incurred through the cost of staff
travel time and less efficient use of staff time. However
this was set against reduced time and travel costs of
women attending [36]. In our study, NHS costs were
higher in the most remote locations, as were private costs,
although the magnitude of excess private costs was rela-
tively small, approximately £3 per subject above the aver-
age. In our study, it appears that potential barriers
associated with time and travel were reduced and access
was enabled through the outreach approach adopted. If
BMC Public Health 2006, 6:80 http://www.biomedcentral.com/1471-2458/6/80
Page 6 of 7
(page number not for citation purposes)
screening had been restricted to the urban hospital base,
considerable journeys would have been required for many
of those participating.
There are some limitations of the present study. We were
unable to link home postcodes to deprivation scores for
8% of our subjects. However, we do not believe that this
would impact on our conclusions as the unmatched post-
codes were equally distributed across all settlement types
as determined from the location of the subjects' general
practitioner premises. Our study was not designed to
assess cost-effectiveness directly. However we observed
similar clinical outcomes and NHS costs to the MASS trial
[7] and thus the estimate from the economic evaluation of
that trial [8] is a reasonable guide to cost-effectiveness in
our study. The total NHS screening cost per man ran-
domised for screening in the MASS study was £23.23,
compared to £15.72 in our study. Thus even the addition
of the private costs for our subjects result in a similar cost
per man offered screening. It could be argued that the
MASS trial findings imply that AAA screening is not cost-
effective given a four- year time horizon. However, given
a lifetime perspective screening it is almost certainly cost-
effective.
Conclusion
In conclusion, uptake of screening for abdominal aortic
aneurysm in this remote and rural setting was high in
comparison with previous studies, and this applied across
all settlement types. Geographical location did not affect
uptake, most likely due to the outreach approach
adopted. Private costs and NHS costs were highest in very
remote rural settings but still compared favourably with
published data.
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